• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Does Profitability Swing And Buybacks Shift The Bull Case For Ingevity (NGVT)?

    Simply Wall St·08/10/2026 22:33:16
    Listen to the news
    • Ingevity Corporation reported past second-quarter 2026 results with sales of US$314.1 million, net income of US$35.3 million, and diluted earnings per share from continuing operations of US$1.13, alongside ongoing progress on portfolio reshaping and a completed share repurchase of 493,375 shares for US$35 million under its 2022 buyback program.
    • The shift from a prior-year loss to profitability, combined with higher full-year adjusted EBITDA and EPS guidance, highlights management’s confidence in the earnings profile and the impact of focusing on higher-value businesses while returning cash to shareholders through substantial buybacks totaling 4,381,177 shares for US$289.45 million.
    • Next, we’ll explore how this swing to profitability and upgraded full-year guidance could influence Ingevity’s existing investment narrative.

    Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

    Ingevity Investment Narrative Recap

    To own Ingevity, you need to believe in its shift toward higher value specialty materials while it works through exposure to cyclical auto and industrial demand. The recent swing back to profitability and higher full year earnings guidance supports the near term catalyst of portfolio reshaping, but does not remove the key risk that the Advanced Polymer Technologies segment and tariff sensitive end markets could still pressure margins and earnings.

    The completion of the 2022 share repurchase program, with 4,381,177 shares bought back for US$289.45 million, ties directly into this earnings focused story by concentrating ownership in a smaller share base while management exits or reshapes lower margin businesses. This capital return sits alongside the sale of Road Markings and the ongoing review of Advanced Polymer Technologies, which together frame how much of the current earnings improvement might prove resilient if industrial and automotive demand weaken again.

    Yet even with the improved results, investors should be aware that prolonged tariff uncertainty and weakness in key APT end markets could still...

    Read the full narrative on Ingevity (it's free!)

    Ingevity's narrative projects $1.1 billion revenue and $350.3 million earnings by 2029.

    Uncover how Ingevity's forecasts yield a $89.00 fair value, a 16% upside to its current price.

    Exploring Other Perspectives

    NGVT 1-Year Stock Price Chart
    NGVT 1-Year Stock Price Chart

    Two Simply Wall St Community fair value estimates span from US$89 to about US$169.67, reminding you that individual views can differ widely. Set against Ingevity’s recent return to profitability and portfolio reshaping efforts, this spread underlines why you may want to compare several independent takes on how cyclical demand and tariff exposure could shape future performance.

    Explore 2 other fair value estimates on Ingevity - why the stock might be worth just $89.00!

    The Verdict Is Yours

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    Curious About Other Options?

    The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.